Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Bettina Meiser


Bettina Meiser

The University of New South Wales, Australia

Biography

Bettina Meiser is and a Professor and Head of the Psychosocial Research Group, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.  She is a an internationally recognised expert in the area of psychosocial aspects of cancer genetics.  She has published over 170 peer-reviewed articles.  Her research program focuses on the psychological impact of cancer genetic counselling and testing, and the design and evaluation of interventions in this setting.  She has undertaken research on the psychological impact of genetic testing a range of conditions including, amongst others, hereditary breast and/or ovarian cancer (HBOC), Lynch Syndrome, Familial Adenomatous Polyposis (FAP), and hereditary melanoma.  She has also conducted innovative research on the psychosocial implications of new gene testing technologies, including the impact of treatment-focused genetic testing following a diagnosis of breast and/or ovarian cancer and the impact of testing for low-risk gene variants related to breast cancer.  Bettina Meiser has been involved in the development and evaluation of a range of psycho-educational materials, including decision aids, for use in different settings in the cancer genetic counselling setting and oncology.  All of the decision aids she has developed for people at increased genetic risk for hereditary disorders are being widely disseminated to familial cancer services around Australia.  She is also undertaken extensive research on cultural aspects of cancer genetics.

Abstract

Abstract : Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision-making about treatment-focused genetic testing: A randomized controlled non-inferiority trial